Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley P Jones

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|April 27, 2017
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic ArthritisAthimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Health Technology Assessment (Winchester, England)|November 22, 2021
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCTSimon C Langton Hewer, Alan R Smyth, Michaela Brown, et al.
BMJ Open|March 10, 2022
Which outcomes should be used in future bronchiolitis trials? Developing a bronchiolitis core outcome set using a systematic review, Delphi survey and a consensus workshopA Rosala-Hallas, Ashley P Jones, Paula R Williamson, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 31, 2020
Optimal outcome measures for a trial of not routinely measuring gastric residual volume in neonatal care: a mixed methods consensus processChris Gale, Jon Dorling, Barbara Arch, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|March 8, 2020
Determining Optimal Outcome Measures in a Trial Investigating No Routine Gastric Residual Volume Measurement in Critically Ill ChildrenLyvonne N Tume, Barbara Arch, Kerry Woolfall, et al.
Ophthalmology|October 19, 2018
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic ArthritisDyfrig A Hughes, Giovanna Culeddu, Catrin O Plumpton, et al.
Health Technology Assessment (Winchester, England)|May 28, 2020
Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: the GASTRIC feasibility studyLyvonne N Tume, Kerry Woolfall, Barbara Arch, et al.
Health Technology Assessment (Winchester, England)|August 8, 2020
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility studyAshley P Jones, Dannii Clayton, Gloria Nkhoma, et al.
Pediatric Rheumatology Online Journal|May 19, 2025
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitisAthimalaipet V Ramanan, Andrew D Dick, Thomas Jaki, et al.
Health Technology Assessment (Winchester, England)|April 30, 2019
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCTAthimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|April 27, 2017
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic ArthritisAthimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Health Technology Assessment (Winchester, England)|November 22, 2021
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCTSimon C Langton Hewer, Alan R Smyth, Michaela Brown, et al.
BMJ Open|March 10, 2022
Which outcomes should be used in future bronchiolitis trials? Developing a bronchiolitis core outcome set using a systematic review, Delphi survey and a consensus workshopA Rosala-Hallas, Ashley P Jones, Paula R Williamson, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 31, 2020
Optimal outcome measures for a trial of not routinely measuring gastric residual volume in neonatal care: a mixed methods consensus processChris Gale, Jon Dorling, Barbara Arch, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|March 8, 2020
Determining Optimal Outcome Measures in a Trial Investigating No Routine Gastric Residual Volume Measurement in Critically Ill ChildrenLyvonne N Tume, Barbara Arch, Kerry Woolfall, et al.
Ophthalmology|October 19, 2018
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic ArthritisDyfrig A Hughes, Giovanna Culeddu, Catrin O Plumpton, et al.
Health Technology Assessment (Winchester, England)|May 28, 2020
Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: the GASTRIC feasibility studyLyvonne N Tume, Kerry Woolfall, Barbara Arch, et al.
Health Technology Assessment (Winchester, England)|August 8, 2020
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility studyAshley P Jones, Dannii Clayton, Gloria Nkhoma, et al.
Pediatric Rheumatology Online Journal|May 19, 2025
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitisAthimalaipet V Ramanan, Andrew D Dick, Thomas Jaki, et al.
Health Technology Assessment (Winchester, England)|April 30, 2019
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCTAthimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.
Pageof 4